LPAR1

edit
Receptor lizofosfatidne kiseline 1
Identifikatori
SimboliLPAR1; EDG2; LPA1; Mrec1.3; VZG1; edg-2; rec.1.3; vzg-1
Vanjski IDOMIM: 602282 MGI: 108429 HomoloGene: 1072 IUPHAR: LPA1 GeneCards: LPAR1 Gene
Ontologija gena
Molekularna funkcija • vezivanje G-protein alfa podjedinice
• aktivnost G-protein spregnutog receptora
• proteinsko vezivanje
• fosfolipidno vezivanje
Celularna komponenta • citoplazma
• ćelijska membrana
• integralno sa ćelijskom membranom
• ćelijska površina
Biološki proces • activacija MAPK aktivnosti
• signalni put G-protein spregnutog receptora
• aktivacija fosfolipaze C
• povišenje koncentracije citozolnih jona kalcijuma
Pregled RNK izražavanja
podaci
Ortolozi
VrstaČovekMiš
Entrez190214745
EnsemblENSG00000198121ENSMUSG00000038668
UniProtQ92633P61793
RefSeq (mRNA)NM_001401.3NM_010336.2
RefSeq (protein)NP_001392.2NP_034466.2
Lokacija (UCSC)Chr 9:
113.64 - 113.8 Mb		Chr 4:
58.45 - 58.57 Mb
PubMed pretraga[1][2]

Receptor lizofosfatidne kiseline 1 (LPA1) je protein koji je kod ljudi kodiran LPAR1 genom.[1][2][3] LPA1 je G protein spregnuti receptor za koji se vezuje lipidni signalni molekul lizofosfatidna kiselina (LPA).[4]

Funkcija

Integralni membranski protein kodiran ovim genom pripada grupi EDG receptora. Ti receptori su članovi familije G protein spregnutih receptora. EDG receptori posreduju različite bioločkie funkcije, uključujući proliferaciju, agregaciju trombocita, kontrakcije glatkih mišića, inhibiciju diferencijaciju neuroblastomnih ćelija, hemotaksu, i invaziju tumornih ćelija. Alternativno splajsovanje ovog gena je uočeno i dve transkriptne varijante su opisane. One kodiraju identične proteine.[1]

Reference

  1. ↑ 1,0 1,1 „Entrez Gene: LPAR1 Lysophosphatidic acid receptor 1”. 
  2. ↑ Hecht JH, Weiner JA, Post SR, Chun J (November 1996). „Ventricular zone gene-1 (vzg-1) encodes a lysophosphatidic acid receptor expressed in neurogenic regions of the developing cerebral cortex”. J. Cell Biol. 135 (4): 1071–83. DOI:10.1083/jcb.135.4.1071. PMC 2133395. PMID 8922387. 
  3. ↑ An S, Dickens MA, Bleu T, Hallmark OG, Goetzl EJ (February 1997). „Molecular cloning of the human Edg2 protein and its identification as a functional cellular receptor for lysophosphatidic acid”. Biochem. Biophys. Res. Commun. 231 (3): 619–22. DOI:10.1006/bbrc.1997.6150. PMID 9070858. 
  4. ↑ Choi JW, Herr DR, Noguchi K, Yung YC, Lee C-W, Mutoh T, Lin M-E, Teo ST, Park KE, Mosley AN, Chun J (January 2010). „LPA Receptors: Subtypes and Biological Actions”. Annual Review of Pharmacology and Toxicology 50 (1): 157–186. DOI:10.1146/annurev.pharmtox.010909.105753. PMID 20055701. [mrtav link]

Literatura

  • An S, Goetzl EJ, Lee H (1999). „Signaling mechanisms and molecular characteristics of G protein-coupled receptors for lysophosphatidic acid and sphingosine 1-phosphate.”. J. Cell. Biochem. Suppl. 30-31: 147–57. PMID 9893266. 
  • Contos JJ, Ishii I, Chun J (2001). „Lysophosphatidic acid receptors.”. Mol. Pharmacol. 58 (6): 1188–96. PMID 11093753. 
  • Moolenaar WH, Kranenburg O, Postma FR, Zondag GC (1997). „Lysophosphatidic acid: G-protein signalling and cellular responses.”. Curr. Opin. Cell Biol. 9 (2): 168–73. DOI:10.1016/S0955-0674(97)80059-2. PMID 9069262. 
  • Fukushima N, Kimura Y, Chun J (1998). „A single receptor encoded by vzg-1/lpA1/edg-2 couples to G proteins and mediates multiple cellular responses to lysophosphatidic acid.”. Proc. Natl. Acad. Sci. U.S.A. 95 (11): 6151–6. DOI:10.1073/pnas.95.11.6151. PMC 27607. PMID 9600933. 
  • An S, Bleu T, Zheng Y, Goetzl EJ (1998). „Recombinant human G protein-coupled lysophosphatidic acid receptors mediate intracellular calcium mobilization.”. Mol. Pharmacol. 54 (5): 881–8. PMID 9804623. 
  • Cervera P, Tirard M, Barron S, et al. (2002). „Immunohistological localization of the myelinating cell-specific receptor LP(A1).”. Glia 38 (2): 126–36. DOI:10.1002/glia.10054. PMID 11948806. 
  • Hama K, Bandoh K, Kakehi Y, et al. (2002). „Lysophosphatidic acid (LPA) receptors are activated differentially by biological fluids: possible role of LPA-binding proteins in activation of LPA receptors.”. FEBS Lett. 523 (1-3): 187–92. DOI:10.1016/S0014-5793(02)02976-9. PMID 12123830. 
  • Van Leeuwen FN, Olivo C, Grivell S, et al. (2003). „Rac activation by lysophosphatidic acid LPA1 receptors through the guanine nucleotide exchange factor Tiam1.”. J. Biol. Chem. 278 (1): 400–6. DOI:10.1074/jbc.M210151200. PMID 12393875. 
  • Strausberg RL, Feingold EA, Grouse LH, et al. (2003). „Generation and initial analysis of more than 15,000 full-length human and mouse cDNA sequences.”. Proc. Natl. Acad. Sci. U.S.A. 99 (26): 16899–903. DOI:10.1073/pnas.242603899. PMC 139241. PMID 12477932. 
  • Murph MM, Scaccia LA, Volpicelli LA, Radhakrishna H (2004). „Agonist-induced endocytosis of lysophosphatidic acid-coupled LPA1/EDG-2 receptors via a dynamin2- and Rab5-dependent pathway.”. J. Cell. Sci. 116 (Pt 10): 1969–80. DOI:10.1242/jcs.00397. PMID 12668728. 
  • Shida D, Kitayama J, Yamaguchi H, et al. (2003). „Lysophosphatidic acid (LPA) enhances the metastatic potential of human colon carcinoma DLD1 cells through LPA1.”. Cancer Res. 63 (7): 1706–11. PMID 12670925. 
  • Matsuda A, Suzuki Y, Honda G, et al. (2003). „Large-scale identification and characterization of human genes that activate NF-kappaB and MAPK signaling pathways.”. Oncogene 22 (21): 3307–18. DOI:10.1038/sj.onc.1206406. PMID 12761501. 
  • Xu J, Lai YJ, Lin WC, Lin FT (2004). „TRIP6 enhances lysophosphatidic acid-induced cell migration by interacting with the lysophosphatidic acid 2 receptor.”. J. Biol. Chem. 279 (11): 10459–68. DOI:10.1074/jbc.M311891200. PMID 14688263. 
  • Komuro Y, Watanabe T, Kitayama J, et al. (2004). „The Immunohistochemical expression of endothelial cell differentiation gene-2 receptor in human colorectal adenomas.”. Hepatogastroenterology 50 (54): 1770–3. PMID 14696401. 
  • Ota T, Suzuki Y, Nishikawa T, et al. (2004). „Complete sequencing and characterization of 21,243 full-length human cDNAs.”. Nat. Genet. 36 (1): 40–5. DOI:10.1038/ng1285. PMID 14702039. 
  • Kaneider NC, Lindner J, Feistritzer C, et al. (2005). „The immune modulator FTY720 targets sphingosine-kinase-dependent migration of human monocytes in response to amyloid beta-protein and its precursor.”. FASEB J. 18 (11): 1309–11. DOI:10.1096/fj.03-1050fje. PMID 15208267. 

Vidi još

Spoljašnje veze

  • „Lysophospholipid Receptors: LPA1”. IUPHAR Database of Receptors and Ion Channels. International Union of Basic and Clinical Pharmacology. Arhivirano iz originala na datum 2016-03-03. 
  • MeSH Lysophospholipid+receptors
  • p
  • r
  • u
Klasa A: Rodopsinu slični
α1 (A, B, D) • α2 (A, B, C) • β1 • β2 • β3
Adenozinski (A1, A2A, A2B, A3) • P2Y (1, 2, 4, 5, 6, 8, 9, 10, 11, 12, 13, 14)
(svi osim 5-HT3) 5-HT1 (A, B, D, E, F) • 5-HT2 (A, B, C) • 5-HT (4, 5A, 6, 7)
Drugi
Acetilholin (M1, M2, M3, M4, M5) • Dopamin (D1, D2, D3, D4, D5) • Histamin (H1, H2, H3, H4) • Melatonin (1A, 1B, 1C) • TAAR (1, 2, 3, 5, 6, 8, 9)
Metaboliti i
signalni molekuli
CysLT (1, 2) • LTB4 (1, 2) • FPRL1 • OXE • Prostaglandin (DP (1, 2), EP (1, 2, 3, 4), FP) • Prostaciklin • Tromboksan
Drugi
Žučna kiselina • Kanabinoidni (CB1, CB2, GPR (18, 55, 119)) • EBI2 • Estrogen • Slobodna masna kiselina (1, 2, 3, 4) • Laktat  • Lizofosfatidna kiselina (1, 2, 3, 4, 5, 6)  • Lizofosfolipid (1, 2, 3, 4, 5, 6, 7, 8) • Niacin (1, 2) • Oksoglutarat • PAF • Sfingozin-1-fosfat (1, 2, 3, 4, 5) • Sukcinat
Peptid
B/W (1, 2) • FF (1, 2) • S • Y (1, 2, 4, 5) • Neuromedin (B, U (1, 2)) • Neurotenzin (1, 2)
Drugi
Anafilatoksin (C3a, C5a) • Angiotenzin (1, 2) • Apelin • Bombezin (BRS3, GRPR, NMBR) • Bradikinin (B1, B2) • Hemokin • Holecistokinin (A, B) • Endotelin (A, B) • Formil peptid (1, 2, 3) • FSH • Galanin (1, 2, 3) • GHB receptor • Gonadotropin-oslobađajući hormon (1, 2) • Grelin • Kispeptin • Luteinizirajući hormon/horiogonadotropin • MAS (1, 1L, D, E, F, G, X1, X2, X3, X4) • Melanokortin (1, 2, 3, 4, 5) • MCHR (1, 2) • Motilin • Opioidni (δ, κ, μ, Nociceptin & ζ, ali ne σ) • Oreksin (1, 2) • Oksitocin • Prokineticin (1, 2) • Prolaktin-oslobađajući peptid • Relaksin (1, 2, 3, 4) • Somatostatin (1, 2, 3, 4, 5) • Tahikinin (1, 2, 3) • Tirotropin • Tirotropin-oslobađajući hormon • Urotenzin-II • Vazopresin (1A, 1B, 2)
Razno
GPR (1, 3, 4, 6, 12, 15, 17, 18, 19, 20, 21, 22, 23, 25, 26, 27, 31, 32, 33, 34, 35, 37, 39, 42, 44, 45, 50, 52, 55, 61, 62, 63, 65, 68, 75, 77, 78, 81, 82, 83, 84, 85, 87, 88, 92, 101, 103, 109A, 109B, 119, 120, 132, 135, 137B, 139, 141, 142, 146, 148, 149, 150, 151, 152, 153, 160, 161, 162, 171, 173, 174, 176, 177, 182, 183)
Drugi
Adrenomedulin • Mirisni • Opsin (3, 4, 5, 1LW, 1MW, 1SW, RGR, RRH) • Proteazom-aktivirani (1, 2, 3, 4) • SREB (1, 2, 3)
Klasa B: Sekretinu slični
GPR (56, 64, 97, 98, 110, 111, 112, 113, 114, 115, 116, 123, 124, 125, 126, 128, 133, 143, 144, 155, 157)
Drugi
Klasa C: Metabotropni
glutamat / feromon
TAS1R (1, 2, 3) • TAS2R (1, 3, 4, 5, 8, 9, 10, 12, 13, 14, 16, 19, 20, 30, 31, 38, 39, 40, 41, 42, 43, 45, 46, 50)
Drugi
Klasa F:
Frizzled / Zaglađeni
Uvojiti
Frizzled (1, 2, 3, 4, 5, 6, 7, 8, 9, 10)
Zaglađeni
B trdu: peptidi (nrpl/grfl/cytl/horl), receptori (lgic, enzr, gprc, igsr, intg, nrpr/grfr/cytr), itra (adap, gbpr, mapk), calc, lipd, signalni putevi (hedp, wntp, tgfp+mapp, notp, jakp, fsap, hipp, tlrp)